| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Luisa Fernanda Ahunca Velásque. [Beyond Cognitive Impairment: Neuropsychiatric Symptoms in Neurodegenerative Dementias]. Revista colombiana de psiquiatria. vol 46 Suppl 1. 2018-10-11. PMID:29037339. |
furthermore, it is important to understand the nature of nps, since they can vary across the different types of dementia and may provide useful clinical information regarding the aetiology of cognitive impairment. |
2018-10-11 |
2023-08-13 |
Not clear |
| Luisa Fernanda Ahunca Velásque. [Beyond Cognitive Impairment: Neuropsychiatric Symptoms in Neurodegenerative Dementias]. Revista colombiana de psiquiatria. vol 46 Suppl 1. 2018-10-11. PMID:29037339. |
the first-line management of nps in dementia is non-pharmacological; internal and external causes should first be identified and strategies developed to modify the behavioural patterns of the patient and their caregiver. |
2018-10-11 |
2023-08-13 |
Not clear |
| Luisa Fernanda Ahunca Velásque. [Beyond Cognitive Impairment: Neuropsychiatric Symptoms in Neurodegenerative Dementias]. Revista colombiana de psiquiatria. vol 46 Suppl 1. 2018-10-11. PMID:29037339. |
however, psychoactive drugs do not offer sufficient efficacy and most of them have significant adverse effects, so each patient should be individually assessed, together with the implementation of non-pharmacological strategies, before deciding on pharmacological treatment for the management of nps in dementia. |
2018-10-11 |
2023-08-13 |
Not clear |
| Iris Zahirovic, Gustav Torisson, Carina Wattmo, Elisabet Londo. Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden. BMC geriatrics. vol 18. issue 1. 2018-07-31. PMID:29454305. |
elderly persons with a dementia diagnosis often suffer from different neuropsychiatric symptoms (nps) such as delusions, hallucinations, depression, anxiety, irritability and agitation. |
2018-07-31 |
2023-08-13 |
Not clear |
| Ryan M Silwanowicz, Donovan T Maust, Lisa S Seyfried, Claire Chiang, Claire Stano, Helen C Kale. Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms. International journal of geriatric psychiatry. vol 32. issue 12. 2018-06-20. PMID:27699845. |
our aim is to evaluate if and how neuropsychiatric symptoms (nps) of dementia influence the management and disposition of older adults who present to emergency care settings. |
2018-06-20 |
2023-08-13 |
Not clear |
| Marta Miarons, Christopher Cabib, Francisco Javier Barón, Laia Rofe. Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms. European journal of clinical pharmacology. vol 73. issue 11. 2018-06-18. PMID:28780696. |
antipsychotics (aps) are commonly used to manage neuropsychiatric symptoms (nps) in elderly patients with dementia, even though several large studies have demonstrated an association between ap treatment and increased morbidity and mortality in people with dementia. |
2018-06-18 |
2023-08-13 |
Not clear |
| Cassandra J Anor, Sean O'Connor, Amardeep Saund, David F Tang-Wai, Ron Keren, Maria Carmela Tartagli. Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia. Neuro-degenerative diseases. vol 17. issue 4-5. 2018-04-25. PMID:28245482. |
neuropsychiatric symptoms (nps) are common in alzheimer disease (ad) and vascular dementia (vad), and are distressful to patients and caregivers. |
2018-04-25 |
2023-08-13 |
Not clear |
| Moyra E Mortby, Richard Burns, Ranmalee Eramudugolla, Zahinoor Ismail, Kaarin J Anste. Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms. Journal of Alzheimer's disease : JAD. vol 59. issue 1. 2018-04-06. PMID:28598846. |
neuropsychiatric symptoms (nps) are common in older adults with cognitive impairment, yet little is known about population-based prevalence and clinical implications of co-morbid symptom presentation across the spectrum from normal cognition to dementia. |
2018-04-06 |
2023-08-13 |
Not clear |
| Victor Bloniecki, Dag Aarsland, Kaj Blennow, Jeffrey Cummings, Farshad Falahati, Bengt Winblad, Yvonne Freund-Lev. Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid. Journal of Alzheimer's disease : JAD. vol 57. issue 2. 2018-02-26. PMID:28269767. |
treatment for neuropsychiatric symptoms (nps) in dementia is insufficient. |
2018-02-26 |
2023-08-13 |
Not clear |
| Zahinoor Ismail, Luis Agüera-Ortiz, Henry Brodaty, Alicja Cieslak, Jeffrey Cummings, Corinne E Fischer, Serge Gauthier, Yonas E Geda, Nathan Herrmann, Jamila Kanji, Krista L Lanctôt, David S Miller, Moyra E Mortby, Chiadi U Onyike, Paul B Rosenberg, Eric E Smith, Gwenn S Smith, David L Sultzer, Constantine Lyketso. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. Journal of Alzheimer's disease : JAD. vol 56. issue 3. 2018-02-21. PMID:28059789. |
mild behavioral impairment (mbi) is a construct that describes the emergence at ≥50 years of age of sustained and impactful neuropsychiatric symptoms (nps), as a precursor to cognitive decline and dementia. |
2018-02-21 |
2023-08-13 |
Not clear |
| Klaas van der Spek, Debby L Gerritsen, Martin Smalbrugge, Marjorie H J M G Nelissen-Vrancken, Roland B Wetzels, Claudia H W Smeets, Sytse U Zuidema, Raymond T C M Koopman. Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study. International psychogeriatrics. vol 28. issue 10. 2018-02-01. PMID:27587349. |
this study explores the appropriateness of psychotropic drug (pd) use for neuropsychiatric symptoms (nps) in nursing home patients with dementia. |
2018-02-01 |
2023-08-13 |
Not clear |
| Kieran Anthony Walsh, Niamh A O'Regan, Stephen Byrne, John Browne, David J Meagher, Suzanne Timmon. Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing. International psychogeriatrics. vol 28. issue 11. 2018-01-30. PMID:27527842. |
neuropsychiatric symptoms (nps) are ubiquitous in dementia and are often treated pharmacologically. |
2018-01-30 |
2023-08-13 |
Not clear |
| Janny Ho, Roland B Wetzels, Hans Bor, Sytse U Zuidem. Gender differences in clusters of NPS in Dutch nursing homes - a factor analysis. International psychogeriatrics. vol 28. issue 12. 2018-01-29. PMID:27572478. |
nps can be grouped by type and stage of dementia. |
2018-01-29 |
2023-08-13 |
Not clear |
| Julia Kirkham, Chelsea Sherman, Clive Velkers, Colleen Maxwell, Sudeep Gill, Paula Rochon, Dallas Seit. Antipsychotic Use in Dementia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 62. issue 3. 2017-12-08. PMID:28212496. |
current controversy exists over the role of antipsychotics in the management of neuropsychiatric symptoms (nps) in persons with dementia. |
2017-12-08 |
2023-08-13 |
Not clear |
| Laura N Gitlin, Catherine Verrier Piersol, Nancy Hodgson, Katherine Marx, David L Roth, Deidre Johnston, Quincy Samus, Laura Pizzi, Eric Jutkowitz, Constantine G Lyketso. Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial. Contemporary clinical trials. vol 49. 2017-11-30. PMID:27339865. |
we describe a randomized clinical trial, the dementia behavior study, to test the efficacy of an activity program to reduce significant existing nps and associated caregiver burden at 3 and 6months compared to a control group intervention. |
2017-11-30 |
2023-08-13 |
Not clear |
| Marco Canevelli, Alessandro Blasimme, Nicola Vanacore, Giuseppe Bruno, Matteo Cesar. Mild behavioral impairment: Ethical, methodological and clinical reflections. Neuroscience and biobehavioral reviews. vol 69. 2017-10-20. PMID:27570153. |
the rationale supporting the need of such novel construct is that neuropsychiatric symptoms (nps), even when they do not configure major psychiatric disorders, may still constitute early manifestations of neurodegenerative diseases, potentially anticipating the onset of dementia. |
2017-10-20 |
2023-08-13 |
Not clear |
| Debby Van Dam, Yannick Vermeiren, Alain D Dekker, Petrus J W Naudé, Peter P De Dey. Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? Current Alzheimer research. vol 13. issue 10. 2017-10-02. PMID:27137218. |
neuropsychiatric symptoms (nps) are an integral part of the dementia syndrome and were therefore recently included in the core diagnostic criteria of dementia. |
2017-10-02 |
2023-08-13 |
Not clear |
| Bjørn Lichtwarck, Geir Selbaek, Øyvind Kirkevold, Anne Marie Mork Rokstad, Jūratė Šaltytė Benth, Janne Myhre, Solvor Nybakken, Sverre Berg. TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial. BMC psychiatry. vol 16. 2017-07-26. PMID:27406242. |
nearly all persons with dementia will experience neuropsychiatric symptoms (nps) during the course of their disease. |
2017-07-26 |
2023-08-13 |
Not clear |
| Kristina Gotovac, Matea Nikolac Perković, Nela Pivac, Fran Borovečk. Biomarkers of aggression in dementia. Progress in neuro-psychopharmacology & biological psychiatry. vol 69. 2017-04-10. PMID:26952705. |
there have been significant and multiple neurotransmitter changes identified in the brains of patients with dementia and some of these changes have been involved in the etiology of nps. |
2017-04-10 |
2023-08-13 |
Not clear |
| Hyejin Kim, Mary Ersek, Christine Bradway, Susan E Hickma. Physician Orders for Life-Sustaining Treatment for nursing home residents with dementia. Journal of the American Association of Nurse Practitioners. vol 27. issue 11. 2017-01-13. PMID:25891157. |
this article describes the history and features of the polst paradigm, discusses the potential advantages of using this paradigm for nh residents with dementia, and briefly explores challenges that nurse practitioners (nps) face in using the polst for persons with dementia. |
2017-01-13 |
2023-08-13 |
Not clear |